AbbVie Reports First-Quarter 2025 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
AbbVie (ABBV) EPS Beats Consensus, Updates Guidance
April 25, 2025 7:45 AM EDT(Updated - April 25, 2025 7:57 AM EDT)
AbbVie (NYSE: ABBV) reported Q1 EPS of $2.46, better than the analyst estimate of $2.39. Revenue for the quarter came in at $13.34 billion versus the consensus estimate of $12.93 billion.
GUIDANCE:
AbbVie sees FY2025 EPS of... More
